Letter by Gazmuri and Karmazyn Regarding Article, "Activation and Inhibition of SodiumHydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure"

被引：1

作者：

Gazmuri, Raul J. ^{[1
,2
,3
]}

Karmazyn, Morris

机构：

[1] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL 60064 USA

[2] Rosalind Franklin Univ Med & Sci, Dept Clin Sci, N Chicago, IL 60064 USA

[3] Captain James A Lovell Fed Hlth Care Ctr, Sect Crit Care Med, N Chicago, IL 60064 USA

来源：

CIRCULATION | 2018年 / 137卷 / 18期

关键词：

D O I：

10.1161/CIRCULATIONAHA.117.032824

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1979 / 1980

页数：2

共 50 条

[41] Novel mechanism of matrix metalloproteinase inhibitor in the treatment of heart failure:: Direct inhibition of myocardial oxidant stress and NF-κB activation in rats
Takenaka, H
Kihara, Y
Iwanaga, Y
Onozawa, Y
Toyokuni, S
Kita, T
CIRCULATION, 2004, 110 (17) : 514 - 515
[42] Letter by Tsuda Regarding Article, "Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial"
Tsuda, Kazushi
CIRCULATION, 2020, 141 (09) : E100 - E101
[43] Letter regarding the article 'Efficacy and safety of angiotensin receptor-neprilysin inhibition in heart failure patients with end-stage kidney disease on maintenance dialysis: A systematic review and meta-analysis'
Zhang, Fan
Li, Jiao
EUROPEAN JOURNAL OF HEART FAILURE, 2025,
[44] Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"
Singh, Jagdeep S.
Struthers, Allan D.
Lang, Chim C.
CIRCULATION, 2021, 144 (03) : E38 - E39
[45] Response to Letter Regarding Article, "Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure: A Double-Blind Placebo-Controlled Cross-Over Preliminary Study"
Doehner, Wolfram
Anker, Stefan D.
Ogino, Kazuhide
CIRCULATION-HEART FAILURE, 2010, 3 (03) : E14 - E14
[46] Letter from Turco Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"
Turco, Pietro
CIRCULATION, 2016, 134 (10) : E179 - E180
[47] Letter by George Regarding Article, "Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure: A Double-Blind Placebo-Controlled Cross-Over Preliminary Study"
George, Jacob
CIRCULATION-HEART FAILURE, 2010, 3 (03) : E10 - E10
[48] Letter from Skolnik Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"
Skolnik, Neil
CIRCULATION, 2016, 134 (10) : E187 - E188
[49] Reply to the letter regarding the article 'Efficacy and safety of angiotensin receptor-neprilysin inhibition in heart failure patients with end-stage kidney disease on maintenance dialysis: A systematic review and meta-analysis'
Nguyen, Dung Viet
Le, Thanh Ngoc
Nguyen, Hoai Thi Thu
EUROPEAN JOURNAL OF HEART FAILURE, 2025,
[50] Letter by Carlstrom and Lundberg Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction"
Carlstrom, Mattias
Lundberg, Jon O.
CIRCULATION, 2016, 134 (06) : E77 - E78

← 1 2 3 4 5 →